AFINUM and SHS V Medtech Investments acquisition of Evitria

14/12/2018

Private acquisition

Status:

Completed

Date:

14/12/2018

Overview:

Financial investors AFINUM and SHS V Medtech Investments have acquired Swiss biotech company Evitria.

Rajeeb gurung - Researcher

Jurisdiction:

Switzerland

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

CMS von Erlach Partners

Party: Evitria (Seller)

Lawyer: Stephan Werlen

VISCHER

Party: AFINUM (Acquirer)

Lawyer: Jürg Luginbühl

Walder Wyss

Party: SHS V Fund (Acquirer)

Lawyers: Alexander Gutmans, Robert von Rosen

Related deals